| ID | 10114 |
| Vaccine Name | RabAvert |
| Disease Name | Rabies |
| Disease Classification | Neurologic |
| Virus Name | Rabies virus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Novartis |
| Year of Manufacturing | NA |
| Manufacturing Country | NA |
| Age | All age group |
| Dosage | 4 doses on day 0, 3, 7 and 14 |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | Purified chick embryo cell |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref |
| Additional Links | https://www.fda.gov/files/vaccines%2C%20blood%20&%20biologics/published/Package-Insert---RabAvert.pdf
|